Veraxa Biotech Holding AG Operating Income

Veraxa Biotech Holding AG posts a operating income of $-3.7M as of March 2026. That compares with $-870K in the prior-year period — down 329.2% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Veraxa Biotech Holding AG's operating income was $-870K. The latest reading is $-3.7M — a 329.2% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Operating Income is one piece of Veraxa Biotech Holding AG's financial statement story. At $-3.7M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VRXA's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Veraxa Biotech Holding AG's other metric pages and overview cover the third.